Showing results (461-470 of 2,810) with videos related to
Sort By:
Pageof 281
Expert Opinion on Drug Safety|December 6, 2013
Development and application of indicators for the reduction of potentially preventable hospital admissions related to medicationsMargaretha F Warlé-van Herwaarden, Vera E Valkhoff, Martina Teichert, et al.Expert Opinion on Drug Safety|December 12, 2012
Assessment of the quality of medication information for patients in SpainJosé Joaquín Mira, Susana Lorenzo, Virtudes Pérez-Jover, et al.Expert Opinion on Drug Safety|August 13, 2013
Enigmas regarding the true extent and impact of tyrosine kinase inhibitor-related cardiotoxicityMichael S Ewer, Steven M EwerExpert Opinion on Drug Safety|June 5, 2013
Antiretroviral drug-related toxicities - clinical spectrum, prevention, and managementJose V Fernandez-Montero, Eugenia Eugenia, Pablo Barreiro, et al.Expert Opinion on Drug Safety|April 25, 2013
Efficacy and safety of mipomersen sodium (Kynamro)Kees Hovingh, Joost Besseling, John KasteleinExpert Opinion on Drug Safety|April 26, 2013
Safety concerns with the long-term management of osteoporosisJean-Yves Reginster, Franz Pelousse, Olivier BruyèreExpert Opinion on Drug Safety|March 20, 2013
Safety of celecoxib compared with placebo and non-selective NSAIDs: cumulative meta-analysis of 89 randomized controlled trialsMargaret Noyes Essex, Richard Y Zhang, Manuela F Berger, et al.Expert Opinion on Drug Safety|March 21, 2013
Safety and treatment patterns of angiogenesis inhibitors in patients with advanced renal cell carcinoma in SpainDaniel Castellano, Mei Sheng Duh, Caroline Korves, et al.Expert Opinion on Drug Safety|May 9, 2013
Risks associated with the therapeutic use of fluoroquinolonesRalf Stahlmann, Hartmut M LodeExpert Opinion on Drug Safety|May 10, 2013
Potential nephroprotective effects of l-carnitine against drug-induced nephropathy: a review of literatureAtefeh Jafari, Simin Dashti-Khavidaki, Hossein Khalili, et al.Pageof 281